Another Parent Charged with Negligence in Lymphoma Case

Move over Mrs. Hauser. You've been one-upped by Kristen LaBrie.

LaBrie has been arraigned in a Salem, Massachusettes Superior Court, facing a 40 year prison sentence. The charges?

-Attempted murder
-Child endangerment
-Permitting bodily injury to a disabled person

The alleged victim? Her autistic 9 year old son Jeremy, who had been diagnosed with a form of non-Hodgkin's lymphoma.

LaBrie has plead not guilty to the charges, which include not bringing him to his chemotherapy sessions and failing to fill his prescriptions.

Doctors at Massachusetts General Hospital reputedly are the ones who turned her in after they looked into things and learned she hadn't filled his prescriptions following a chemotherapy regimen. The medication was meant to keep his cancer in remission. It returned as an incurable form of leukemia.

According to her lawyer, LaBrie is the real victim here. Her lawyer says the kid's father, Eric Fraser, abandoned her and Jeremy, putting her in dire financial straits.

Fraser, meanwhile, is apparently pleased with the prosecution of his wife. According to published reports, Fraser swooped in and actually took custody of Jeremy, getting him care at a hospice in his final months of life. He died this past March.

While news outlets want to align this story with the Hauser story from Minnesota, I don't see it. As much as I was opposed to the Hausers fleeing the court, LaBrie's merely looking-- true or not-- like a terrible, uncaring parent. For all her actions, Hauser could never have been accused of that.

Sources:
Associated Press
Boston Globe

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap